{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2-dev",
    "document_metadata": {
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies",
      "version": "1.0.0",
      "authors": "Esther Wollert",
      "description": ""
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "tau/shelton2017.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "withaferin A",
      "id": "a4f39f117edc83f3f7f05a5b862858853835a78e63f4bf48aacf59b64022e12835d7db297de02f78b6056946db1da34ccf66e4569f6145649c9d6075db08eea2"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "ATP",
      "id": "dbc5553fb6213ed82215c03a89950a37045e23683ffa96b44532f3e75d204cc547a974025c2799c6a189ad0c5045d96b16d1f5f7ac9296473ba1c647499bb3b2"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "celastrol",
      "id": "442df768d5e3ed403a05cb98460ed844c9db1528e692ed6eebc758a76e53610c17c7d6639db9b84b96f5b8ec67f945dc37fc8d0e4b49ab8ac9f17fe30bf14095"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "tanespimycin",
      "id": "409d39722f4d5c9457a215c12a920d2bf82d03e7f143571a2ce44293d3b8a741f96f61f35a43f0580f6588e3a11c62fc1888fcdc048311e8b3180dc20f703944"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "KU-177",
      "id": "de4ba6aa9d3d65b8a51f8c6f40c5c647c87941664a19e4e08de3091c9825734b6330d14d7e7eafcf25adad7227d20fa54225efc004b0f67c25b85060e93bf006"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau aggregates",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau fibrils",
      "id": "cd2dab27f628336ca0ed44605c7cd92f2fd119b914305cba845b06c61ab768ecf96cc32e4679b8ca5361f3e5cd3bd2418c91526348cc067d58282b812be1310a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Tau oligomers",
      "id": "d4ceff8aa5a5d05770aaa29b828d003b85d64e7e5337c6624b7c5a84111845897462b589e7b259b0eed6bcfc63f34cdaf1f9b988c788804799aea026d8731d98"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "EC102",
      "id": "cd1b77d343ac7873cbf6d1066342dd8eee407e8297ea1aa90b07af67324e9d2865b440c27ac952d2d8d0827a77ea0f2f72d98df1748933412d7af7a1db168417"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Molecular Chaperones",
      "id": "cbd4d8183b7cd578b96afa148739bb4ae10720d38c4936bc957976341d71ff395011e8e37ffcd1b58bfee79d1fe5a0b7306d8c6555580cec4dcc22fa2949a56c"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Immunophilins",
      "id": "cb2754ff60aad0ed2de6bb11f4675d7ff996868b4e3927726adf7929281627987fa7006c3e204f415a7188935203daeb8a16a451fd379c13f36caa8b3cc5b2c3"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "14719853",
      "id": "34879a4797dfd9d3db2a3da2c25a5c7e74678ae6fba01f7fbd652a14464901a05d8e36446d90fb2d7438075794931229236442f085eff03e656482722be9e162"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "162859",
      "id": "ba4eb0253ce317205931b229130854bc486e16ca1511c15ea3be716c1cac5721bdd7e452f16dfc01c8585b8ac6c40386726cfceff2e69e3b687382877914392a"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "4456430",
      "id": "1ed69e073e4d53a5c5805d2d87afc920369e089ffeed7e823d6daea85160e34925857c38816253ed599c48b83dc80d25ce76380283eabcf6ba01894e71939436"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "ATP metabolic process",
      "id": "6fa41f38953b19caed3b9495a93b66582242b79e5ad97c32d96cd971eefd925ee5866079bd60ed0d35fd62f092da34091555cbcb9ddfb3371026649547241370"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "adaptation of signaling pathway",
      "id": "930b2b398f24afa11e7bce96e920b2b5c6df0c93f279aae53df9f87938d3a4e374abde4349b6b74697542d37d779af2b5d7d8b772f93a39684ee11a624d7e075"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell death in response to oxidative stress",
      "id": "fde42377a4eefea9dfcf9fd6bdafa4bad0037a7589e55f63818def5cbb9348eaf12ae719d6268e1de6c66acbc81bd659712acbbf18048aab6613ee37cd62b0c1"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell maturation",
      "id": "3666f457957bbaeba56354bc636e4f77979a24cc9b2ad9b3e877b4e02aa68a84b2437a7a3f429c0414aab20fab1caffd89e4c4c3098eaa17e537ab47354adb50"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "chaperone-mediated autophagy",
      "id": "1becad934ecf26ef0dbbb6985a45169a688cfeb4825fbe7b3534fe465a70623a05fbff45ee7812a49cff207a8c0fdfbb7a9f2083bcbeb7f609f31b3d9d0ca6b0"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cytoskeleton organization",
      "id": "0f233bb914b276fa0c8049201fc757064f83a124d7ef419c9f5c255825f7a5237bf0cb2d759549b349fd98b9cddb82e1f678068f71e7210609d95e118978e99b"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "embryo development",
      "id": "97c2cf14c67e9d70d15f6ad28d6acded1ad0d6365736c1902d2aa4d7575f02cd42df242114d2b49b8e45e29a41677079fe733451ec56bcdbebd46a357172da55"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "glucocorticoid receptor signaling pathway",
      "id": "b4acf168256e00db70e22f2605635aed831bd5eaf3f1d142e4ac8ed6657e23ddc8214c2841f1549746455f13000888a1a6454164ed5848f26c1b90b559d832b9"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neuron apoptotic process",
      "id": "b9dabb1ef70e6265bcd2b24c2109961235bb35268bf9525a7ce468bd3244274273d156fc8c743c001d71896f7e3fc4dd9cf8a2e06ecf33e2f55fba778d2fa6d7"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "protein folding",
      "id": "3f283920a665a68c31087027b6be2cdb273deed17a908552364c1e9eb8400b4a849fe1aa46834cda0b7700391db3fe73a7603fc9b3336ee7aaf70deffee39189"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "protein modification process",
      "id": "35dce31d2fee0924eaa33d831acb702573a33a90471ab753b607092b4e9d52234b807eb74dd8a9f7c93b84dc40053f5325d4d68b113dcfa59e174d088c455413"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "regulation of cell cycle",
      "id": "f896005351b57dac69a99ab505353afda60cec4324cb3d200aca9faabbc3e771a151f17055683e5c4f600d10eed9c3cfd9e2c4b7515d917c02415c40b9241096"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "signal transduction",
      "id": "d3608eaee3f25f464803835ebd517e72f6846b665d75d61b45c66a6b129b218063af2c786170c0ce992cee3a5dbad92aa0cc0ab20038b430436f70147d366e4f"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "growth",
      "id": "4c345c2b01972d468b6846b0786441ea7a8dbcc5aac70935c795db518857fdfd3f3ae6fb09b374aa9f37a71543107229c4a28a3decc13ae08d6044fcca22cc7b"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "memory",
      "id": "87795d00588bdf77d28229ad379d58f00922f6339902a803d0672cc15e669269f8fe50785b2851e1e82046f4e1e49920534ec68c0b6911bea5a1b838dbc999cd"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "Proteostasis",
      "id": "f9272dc303dc1a40e183bb77429a416f78ef2b95b207dfda09c188a5789b1cf6ffcae723cc4a6f351c915509c1e9e99ebc1daab87872ce60a6cb83b2122b39f3"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Aging",
      "id": "175e5d777b693461a2f6189ec21aa1f8324f054bc8acc641df82819a4c04776202053094a1c12915bdfd2244a6a5f639b7008b7f8e9a5ffea3c3b8aaa255d1b9"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Cytoprotection",
      "id": "8dec510e5b8ecf86bb7254e9e452b6bd721ef4e074907ebc95b3d825a2ae8d489758a8c56133d372ddaea68b97b8460d662309606ececf6734e57b969d8260bb"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Proteolysis",
      "id": "08f053829da37141585f38cef26f94f8bafbf2a652d28dbc4e952f33f072050ade09d03562130b4ee0ada625c0d484d2596c22c2d3a4bd1e5567fa9999c5df2a"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "ATP",
          "id": "dbc5553fb6213ed82215c03a89950a37045e23683ffa96b44532f3e75d204cc547a974025c2799c6a189ad0c5045d96b16d1f5f7ac9296473ba1c647499bb3b2"
        },
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        }
      ],
      "id": "2d3538dcfa1423b4f7f471758999df90f10983a63e74a92cc29ae60101c562f9b1bd338aa7992560af327a3a3e0eaaaab68fb6965f46509af51483cb575d1a51"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "AIP",
          "id": "871251c5b54de6b459d49dec2253c20bee1126594ca090daee27f35d66bb83cad0f110d554abbbe65fff8a2bcea5ab06e6fda6efc90c1938e8aefa4c849e361f"
        }
      ],
      "id": "d1e6d78abf9a01f166d9927ad682167ae8abc410b8243318b360bc5a6949b2a41b4149e62e32328416e74c95b6c92051f1aadc09c21337a01ed755627a57193c"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CDC37",
          "id": "926e7052adcda63d68ea1ea2a8c703a4652ea6ab6b281e9462ad243171de9ee72dadad40e0ca15c988cffc2580dcf4a9a0383eaea52c091eed2e0a4b395359e9"
        }
      ],
      "id": "2d70ae63224588a7cd3c34679ce649553f4b40308c5f24cf9de4a1b74a5edaf8e932df109f683a4a6d2eef11cd22192f3366c26a8e654d476f0e340c801afe2f"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP4",
          "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
        }
      ],
      "id": "f171b42be11821386704cc635749ccf52b50be36fcaca28331b0e587e59af085cb0d79c2d84c0ef0edc33da8b3f04efc0522f6e2db472b50371085f5e3360d77"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP4",
          "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PTGES3",
          "id": "743fd8f60493bef225875a48d1e2b407ba42f50f44599aad5c556c443395a0f89e397754ace47bfc9433603285bf7499f4ddf8a568b10821a3c260f508c7d69a"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "STIP1",
          "id": "b370e8c93a9fd4a6879ea0c4467c8d4380531fd8a3f1d11edadc2f87129929639d62087b071694e5937f4278fc6fb00d65ef937930fa462de94fa83118735ead"
        }
      ],
      "id": "c6edf1320a1ed18d04f9a072fc7e5b3bf44d2ac0065d2244382fa08e0a37fb29781120afc98c212eb261f43686217855115395aaa22b6e642bc59b2a96275820"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP5",
          "id": "235130a6aad5392b8d93ce87ee8c3548278ee308274731183499ce12dda8591cebd72053e22806a7c74a50cea9078cc291520f2bb9b1af2eb56e3880dd8d73ab"
        }
      ],
      "id": "f6d435bb0f57fea31ad0705da13d03742ecdc06c987ffb03a38353e7e211b28178628dd9824cad41356633ed25380a9a2ee76fc767f12f48c81cc6ec80c1fa25"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP6",
          "id": "aa1183700c8e41f87b2b72493c5a0c1140abbd565a360b4774aad7116b341d7edd2d7b9068cd075ecc9d6a6faf167c3eeba95a7f0068cf856a86e7e84a84fcee"
        }
      ],
      "id": "e93d5aefd99f230380388e05f95d825b28d0102c7e2670c8268d360526afe62c0629aca21c875f3896c2090afe576350f40cc735af96e703b8779bcfe8a66b07"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP8",
          "id": "ca15345ed96dca4ed1f2a02f130ceeae40d56e291a2c5f276efa9f1d03e9d4e74016496c82f296733c127907f13b8736a10ec0e1b4b000ca0396831f0e9c78af"
        }
      ],
      "id": "d59125fb555d0723d87f00e8906ca8d15e831c5f405cda89efa7d1041f79b5a587efa4a2f32cb5bd85da0d6a0348d37490e17a0313ce30ff63b7fe8f3e1879b3"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBPL",
          "id": "d8ebb2087d5022829dcff7a0e8de7f9fc0ba8d3fa025922a4cba9f0f9f80dd66a87034fe33b221bc56b31b52d81a7e356de7d14158ecb5b62865d5cb44904843"
        }
      ],
      "id": "9d1020626c34da712060f59245516f102aeb4715b2f5fd3544b27a5b5817318a1def5a804a053e4143831b1896f1335c93a8e07d700de6a0144d36d911603938"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FNIP1",
          "id": "cb64cfb66a14b54505c4eece6137362a94d205c953d9bb5fc27b77551bda4d3d30759206d52634546fa26f4b22572eaecb9e036497020af4e18b1267e24aa47e"
        }
      ],
      "id": "199db7a6f8abe3cb9c6d830d49241312b528cef5d956ca72173e113d9327ea4a76d4d2b7dd65d4f74a743acd3ca2ef4fdbdfe7463fd29174b108331522d59e52"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FNIP1",
          "id": "cb64cfb66a14b54505c4eece6137362a94d205c953d9bb5fc27b77551bda4d3d30759206d52634546fa26f4b22572eaecb9e036497020af4e18b1267e24aa47e"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FNIP2",
          "id": "1290e83edc9c0ba92bb9a7ef4a6d317d04cf0878456e979ac6cd68a278c5f040f9a3cf56213795498c6d3a17efa2da2314579c999f3af625e426b23a0b3ff861"
        }
      ],
      "id": "08cedf92e34daa73b269052fe42ddc85c1a9ef00b0ac752861803c484645242a445fba1ed8e457d4f474b7eb54cc4ef6f0586d0c956bd08eb9bdb582f6affb3d"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PPID",
          "id": "8e4a8a2e2a16c9f0c3f06128421ead7ba38bc46de44f1380ae7148c93133b5206ec081d315bd2efd606b30eb69bc2399a00fb36353a7d6d23ebd995c499c95e5"
        }
      ],
      "id": "518b0f10212b04b6687ed604bd731805b78ccb5eb1110f1c1a3f03144c5a7031457c821ccc0470a7246c8fc6b89ee6456372de6bbbe5f5bbd7d7b84b5a46b0ba"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PPP5C",
          "id": "fb42b597325b4b19c18f87893065075af732edf8113519b1b370391d340983fca2da6f260b522019521ec0431bffff6a1b0fd09594442394f300fb69a55f70f4"
        }
      ],
      "id": "35a45331983f042102e38f851ac1c2d25c5ff7180da117216a8d32ec5aa415015fd1e6d9933e100b5145cc07e2cea9711a658a3798a7647f2e10520d81bc60e4"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSP90",
          "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "S100A1",
          "id": "f9f8769cce93ee5100038b059f8bf04c6e1571ce1bdc677ded13c8cebc65c44672da87d5e3625c824b4cd887d8b0091735dd028f7e9bdbe01a27980250c2d4de"
        }
      ],
      "id": "35b2446d69df1971f01f9fd62c21c7032a283613b9829bf9f92d6cb61b448c955216f312719e06650efd5dd49174ade7e23fa1b43f3786f3765aa5a791189482"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP4",
          "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "50a6e39ea38b9df8cc8509e1b8c4bd267f4347942e6e789317222050d3ca064104998e82e1c73d14bc01f8f3be10865b6542cda873aba4f7a2ddd22be35a8cc8"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ac"
          }
        }
      ],
      "id": "4522ed0c2d7fd2b561af50c5a4c881d1e0977dd667720649cc70c93fceff6ce7836acefb2ab2597a3a906a8f764cef5018821e74aca9b99428151ed25561d736"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "NO"
          }
        }
      ],
      "id": "1acac98832a8800621e0cee64a038480d62785bc7c1046ccc43ea30126961d2775b1f8bdde8f119a9db07d0a45ab8afd343076579775a65e5e8a1d23f4630ec2"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "c2d39ef683359f6b028ee6c02f9a4c07996b9c8b4225f6f0edfe2b2f1c41d5582fb0076ed31a46417d739bcba248a9d49af76871197ad2a9edfaed7a4715db9b"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ub"
          }
        }
      ],
      "id": "8cb1ee994e5b00e334d751b57dba3b472ec05b9be6cb739c64bfb5305785eab0adeba2e0e4e258a1fbddcdb62eb8e8137ec0f885671ac9752e15e2b8e22bd598"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "Proteasome",
      "id": "645bfb1e8fc6c1ec119c660999773cfddcb4cf0f2f8f8c0e07af96aceec91f6e5218098423451401e3da7ba628a36a7437a426ca75f5ca004f97d56d7bbfd541"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AHSA1",
      "id": "11a853fc14b77522314fab2709c38add5e956dac10acc0070da97ad317b2909a68d9795388464aa588c7e7ef51c9bb0190a3f168750c1e687b6ce1707eb4f9a0"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AIP",
      "id": "871251c5b54de6b459d49dec2253c20bee1126594ca090daee27f35d66bb83cad0f110d554abbbe65fff8a2bcea5ab06e6fda6efc90c1938e8aefa4c849e361f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDC37",
      "id": "926e7052adcda63d68ea1ea2a8c703a4652ea6ab6b281e9462ad243171de9ee72dadad40e0ca15c988cffc2580dcf4a9a0383eaea52c091eed2e0a4b395359e9"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP4",
      "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP5",
      "id": "235130a6aad5392b8d93ce87ee8c3548278ee308274731183499ce12dda8591cebd72053e22806a7c74a50cea9078cc291520f2bb9b1af2eb56e3880dd8d73ab"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP6",
      "id": "aa1183700c8e41f87b2b72493c5a0c1140abbd565a360b4774aad7116b341d7edd2d7b9068cd075ecc9d6a6faf167c3eeba95a7f0068cf856a86e7e84a84fcee"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP8",
      "id": "ca15345ed96dca4ed1f2a02f130ceeae40d56e291a2c5f276efa9f1d03e9d4e74016496c82f296733c127907f13b8736a10ec0e1b4b000ca0396831f0e9c78af"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBPL",
      "id": "d8ebb2087d5022829dcff7a0e8de7f9fc0ba8d3fa025922a4cba9f0f9f80dd66a87034fe33b221bc56b31b52d81a7e356de7d14158ecb5b62865d5cb44904843"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FLCN",
      "id": "2e70869666d7f7b0611fa911a0bb6f0dfb2805c8a1803d1431844decdf9e58abed6ac1f2a77bd5c33cc9a1ff28fd77859c5bf39ccf6b960b7eb2678e3ef3f108"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FNIP1",
      "id": "cb64cfb66a14b54505c4eece6137362a94d205c953d9bb5fc27b77551bda4d3d30759206d52634546fa26f4b22572eaecb9e036497020af4e18b1267e24aa47e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FNIP2",
      "id": "1290e83edc9c0ba92bb9a7ef4a6d317d04cf0878456e979ac6cd68a278c5f040f9a3cf56213795498c6d3a17efa2da2314579c999f3af625e426b23a0b3ff861"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GSK3B",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HDAC6",
      "id": "c6e2cb3c91ba614ec9e19574656eba9d234344b755f57479d99a4d4ff77acc4917594446b9b19f9823e8a8a0d2d457d74b6f6a582d9f360f13df4136d902c7c3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSP90AA1",
      "id": "0a4f6eac7753a28817f8fe72ea9fa6b2ef63b828454a1beeb67696e1f27223bc0635aa8666d001cd33cc123313bd369e17d1229efaa6a80cedf72aa76efd3290"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSP90AB1",
      "id": "6aa56d18c328e87c34e870f7b02913e5d6efc404b4ceb714fa7b67f3bac9a90781af94a70ebfc3b8340d7a663779c93ee9be4635ee5e56db036a319e57fa7ffc"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPK13",
      "id": "09a8c9fcd8ff34d51d5dbacf813c1c2b7416798b5aedcbbf8e7b2a783a24ebe74a03e37c192a512bf7e4194e4fe2260780d2525d89dc43786ddf3e2a6da378ac"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "HBP",
            "name": "hyperphosphorylation"
          }
        }
      ],
      "id": "ede67fb639f29861d91976fefa16d8279b53ae13a659f35d70ed12e01bf3f339ffcf701fc54c7c4e908fee9902c02aac3e0022dcae5a7afa217ed2d4dba133b0"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "HBP",
            "name": "misfolding"
          }
        }
      ],
      "id": "c93555944a4756ac2bc389b04bbb546c18448b0cfef3567e00b8ca0defc20052ee8bcb4f67d97fa6552e256975d7073b7ea38f9efcfcbb5ae2ba772dec0e734d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "40a1fcd2e6b4af4d7f275f7ffae5cd34aff043c40297e912ed0e45c5a645d1abe2b717042d39ef0fd11ffa06c96785d31a8c7af123db21c2162d4e6ab59b9729"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Pro301Leu"
        }
      ],
      "id": "69abd82dda56f5ab5ce8a6536350e0d44945d6d00ecff099a36fa97c05ac6435b6ddbac8400692d7b1b5c86850a820df0f7558d8fc0ec4d17ac23eae8501f650"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PPID",
      "id": "8e4a8a2e2a16c9f0c3f06128421ead7ba38bc46de44f1380ae7148c93133b5206ec081d315bd2efd606b30eb69bc2399a00fb36353a7d6d23ebd995c499c95e5"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PPP5C",
      "id": "fb42b597325b4b19c18f87893065075af732edf8113519b1b370391d340983fca2da6f260b522019521ec0431bffff6a1b0fd09594442394f300fb69a55f70f4"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PTGES3",
      "id": "743fd8f60493bef225875a48d1e2b407ba42f50f44599aad5c556c443395a0f89e397754ace47bfc9433603285bf7499f4ddf8a568b10821a3c260f508c7d69a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "S100A1",
      "id": "f9f8769cce93ee5100038b059f8bf04c6e1571ce1bdc677ded13c8cebc65c44672da87d5e3625c824b4cd887d8b0091735dd028f7e9bdbe01a27980250c2d4de"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "STIP1",
      "id": "b370e8c93a9fd4a6879ea0c4467c8d4380531fd8a3f1d11edadc2f87129929639d62087b071694e5937f4278fc6fb00d65ef937930fa462de94fa83118735ead"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "STUB1",
      "id": "7edf63ec4c2eaacc63944e79144be59c6ded86334f97e772d1e6ccbca7065106451bd7861e8acfbda8051ed22ecf6451dd68a33a35fc2d3b91083a48b53e1c68"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TOMM34",
      "id": "3d3777bdeb11b79efdd9650552be55d5203c954d6f19a0422d7854ce34be99e12ac99177cdd2689852b82e98b4f3aa03744af66781f0bbcde9e2a2cbed23e612"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Chronic Traumatic Encephalopathy",
      "id": "722029bc4287b44ae98bf376f9f8e4541b041f74195b8b8b43947dab3fa001577811cd0ac61270601c5c6b58478f925752c786f1c5d81659c45799b9435cb2eb"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Cystic Fibrosis",
      "id": "92d6a73efe4b20a749797fccf56afd363e38df6696fcf30eb3dfb7c87e0f8466e00c74afa399bac7bca38017eed893cefb8ff8de2bce5827dcc432bde7b2ca67"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Huntington Disease",
      "id": "1879e0f73bb6f3f680c5793e5c3b9370792a52545c46d4ee9f41a8ef46edd5ba61400e77effb39bd0d1e7f3de6470e091c5d8e6c5beed8d780456b6740a4406c"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neoplasm Metastasis",
      "id": "3a6b8bdf71f489fbffcee8ee1b82d0647dbb619a647a53adc4f9bd6a69ffd22353a34f830e3b36edfaa7d59040b3cbecc5deb099101aace355c0cde7214cfe90"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neurodegenerative Diseases",
      "id": "95863a6d11beb3bd993523e1c8c7e210d281b0c092553f6a4cf27dd3ecf2fa51b49c5056b8aed6f7ac7c82f99101c34bc9fc0afc3dce117fe011d159ba9e4c89"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Parkinson Disease",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Pick Disease of the Brain",
      "id": "7917fa738d79ac0c2819622046fe373e477ef318b8693a75fd3871cd7df292afac3f425f2393f72cbb2813ca81347b925f64a4b874ca7d64c778c9d6e189eead"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Protein Aggregation, Pathological",
      "id": "46c415842841b034fc97a69dd54cb4357bd60585802d3f9e8f1a48802ce28b882da2260272dee02c592a7f90e8fb3dc722187e0e301491eb30ee5b803305a65a"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Supranuclear Palsy, Progressive",
      "id": "06432576e845db5beb8ae7a4c0ae23454b691ca1773f3467bbd58f6ce3d484e768e57b6abbc21258bd43941d8ed10874fa0d45b24d91638ed7e42dcb0e5c7dd1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neoplasms",
      "id": "3acf430fb763193b79a4e43ffc2cbe0822fcb8cb68c26ff93e614c1d6a7dc63fd8afca2116db60243419623d330c5085b60e421eccd5406ac8edf17d2340b500"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Tauopathies",
      "id": "d2087b32a76c528191af8305652f4664cbeb31b3f4e3f9627aaf61259e271f83a7d1be65f83e9178ccf3811482ece65b940fe4ce9a714b2281f705c0d499502b"
    }
  ],
  "links": [
    {
      "line": 85,
      "relation": "association",
      "evidence": "Aging is the biggest risk factor for developing a neurodegenerative disease, but the speciï¬c factors which cause these predominantly sporadic diseases are still under investigation (Reeve et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 88,
      "key": "6411591898b4c5455bf16450535f9df8c255a923319e26adac45c95951a31ef26e1c5cbcddea4d2a1151e7979c4fa360ca927f3633daac1fb10f694a4f9c8773"
    },
    {
      "line": 91,
      "relation": "decreases",
      "evidence": " Not only does aging lead to an increased likelihood of protein misfolding and aggregation, it is compounded by a decrease in the eï¬ciency of the protein degradation machinery.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 23,
      "key": "4890002b5cbb7ee4628665544c160c9a91c759738165977fa7a4263fbc3e30105a897a0e038bba88c8eb41c965333af4ad9550f13b5c2fb96bb8f2b44ec8005e"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": " Not only does aging lead to an increased likelihood of protein misfolding and aggregation, it is compounded by a decrease in the eï¬ciency of the protein degradation machinery.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 91,
      "key": "58c190ef88cc233f504f356a2646951a74f99b5ba95770b163a0136fd64d3c653311019b335ba2641d5a5eeaae9dda799216e8bef0ead3492cd3d52aa8c38994"
    },
    {
      "line": 93,
      "relation": "decreases",
      "evidence": " Not only does aging lead to an increased likelihood of protein misfolding and aggregation, it is compounded by a decrease in the eï¬ciency of the protein degradation machinery.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 32,
      "key": "76ee6d04df8c3212e12e3b1b21e2384a270bd0e6d4eea8f9343ba6a8e0e91f904f8e35c233fd106339b6787fe78dbfadf53ec880e2f2d83243fbf3ce6a3b7fd7"
    },
    {
      "line": 102,
      "relation": "decreases",
      "evidence": "The activity of both the proteasome, which is the main mechanism of protein degradation (Rock et al., 1994; Conconi et al., 1996), and chaperone-mediated autophagy (CMA; Cuervo and Dice, 2000b) is signiï¬cantly impaired with aging and is especially pronounced in post-mitotic cells, such as neurons, potentially resulting in neurodegenerative disease (Terman, 2001).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 30,
      "target": 53,
      "key": "173e5f8c6c53120d042d5976058ee3340b10148cd10e6d22ca75932cfa0807ee20b7da4bc5c995bcf4d1aea43f81fd8167c9a8fbbe8b90180fb2818df7bc8291"
    },
    {
      "line": 429,
      "relation": "decreases",
      "evidence": " In addition to the problems faced with an overwhelmed chaperone network, the proteolytic activity of the proteasome also declines with aging, and in fact Hsp90 has been shown to protect the proteasome from age-related, oxidative-dependent decline (Conconi and Friguet, 1997). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 30,
      "target": 53,
      "key": "97b98cb9b5b4876dd8b894e09c44e4ce063b2a1e3c3b685aa5733d926177d6429cee5c240f4f4e658eb071fd7a7b3d32bc1a58e19f0b4c97733f368e0aa6790e"
    },
    {
      "line": 103,
      "relation": "decreases",
      "evidence": "The activity of both the proteasome, which is the main mechanism of protein degradation (Rock et al., 1994; Conconi et al., 1996), and chaperone-mediated autophagy (CMA; Cuervo and Dice, 2000b) is signiï¬cantly impaired with aging and is especially pronounced in post-mitotic cells, such as neurons, potentially resulting in neurodegenerative disease (Terman, 2001).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 18,
      "key": "6b984ab7246fd79e44ea6196f2fd1306eb6e626365bbd4046133331f03e9f022f1931638ab698de5f7b73c2bec36c817e7734332dff020d55d6c02b0e0a00d5d"
    },
    {
      "line": 434,
      "relation": "decreases",
      "evidence": "Proteins can also be degraded by CMA; however, CMA activity also decreases with age (Cuervo and Dice, 2000a).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 18,
      "key": "7680566ccdb12ca2b945ff60de530d0ac5090741ea4c704a34057b3b8d0164110c92559652d4c2c7ae0e85026ef8dd425f8d9e8df69e6c535e5db215e7a39ca2"
    },
    {
      "line": 190,
      "relation": "decreases",
      "evidence": "An interesting PPIase, CyP40, decreases in aging and is further repressed in AD (Table 1; Brehme et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 76,
      "key": "025e37b08b8029adc8971bb666b9f692d10760acef6d4b5d3bcc67a4cef2d9999715e3fa58008934ab0fdb59c21bc70124a4e7bbcc59cae552f6d12cb2a90ec2"
    },
    {
      "line": 404,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 76,
      "key": "66b367ef57543f4f9e28386aa124b5deec05dac31326d7cd8b2a1c14a2da81d44a60dffbb4a496d0822259bc1fb0d6063a06d80553fbe0be097b2be23c88d01c"
    },
    {
      "line": 216,
      "relation": "increases",
      "evidence": " However, throughout aging, FKBP51 levels progressively increase and are further increased in AD brain samples (Table 1; Blair et al., 2013; Sabbagh et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 58,
      "key": "273529649d6c8fef555e0ba84eaca4fb9ee4c8dbf12c2c993f1dfc968d968121e221b6e75f7800308eab0e95a8d986bb2bb40051099ba0c714cd008460035c86"
    },
    {
      "line": 415,
      "relation": "increases",
      "evidence": "Interestingly, one co-chaperone is signiï¬cantly induced in the aged brain and that is FKBP51.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 58,
      "key": "9212f1bf1885e5a733c9d549066f872ac39295d62d8e947a758334ac1db01f2ba12dbe96bd25b166d4d75f1252af1242af747c7b51a4041713a24144e8a83b02"
    },
    {
      "line": 248,
      "relation": "decreases",
      "evidence": "Another member of this family, protein phosphatase 5 (PP5), is repressed in aging.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 30,
      "target": 77,
      "key": "425882625b8ec91acc9826f48f8550db3188433f0e245668a0e1c2cc6e2e21ad5374695dec73683c57fa916e032a83ccc524de0ccbde62c1d1de336f98ea9394"
    },
    {
      "line": 406,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 77,
      "key": "273e56756c1a1e455f39f254af78e2da9ed04858333ab8994058dd015c804e1b91188a4a8324efa875e88957e35022eea88b3ee8dfc71299e9141aa1e7de6748"
    },
    {
      "line": 322,
      "relation": "decreases",
      "evidence": "Since Aha1 levels are repressed in aging, but are abnormally preserved in AD, tau aggregation could be accelerated in part by Aha1 in the AD brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 30,
      "target": 54,
      "key": "5d39c336e88420cac89a6c3514a9d2f77e280e4fc4ed472157af216eceec22775d9313c2aabd1791409e803c8e23674019d74ac5b72507c35606fad8803fd0f8"
    },
    {
      "line": 409,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 54,
      "key": "1e7dece8ce9a3d0c5a4c9424f5be0a62bb405e499c6b1a12c2e90fc7c65be2eb9f1aa6570e5df5efdbee65a4601aa4a929fa5f63f42e8d258ac821c13ffb3066"
    },
    {
      "line": 382,
      "relation": "increases",
      "evidence": " One study focused on the basal levels of cytosolic Hsp90 in peripheral blood mononuclear cells (PBMC) and found that in aged human samples there was an increase in Hsp90 under normal physiological conditions when compared to young samples (Njemini et al., 2007). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "Cell": {
          "peripheral blood mononuclear cell": true
        }
      },
      "source": 30,
      "target": 48,
      "key": "2cf0df586a3de80af000ef9b6a5ab73743a21cdaf3645c28d421bbed61c9caf52326d80682cea583f73b3ce7bc1596370fd2b580fafa5a536aa26ad7e04d0b1f"
    },
    {
      "line": 389,
      "relation": "decreases",
      "evidence": "Conversely, there are also studies showing decreased levels of Hsp90 in aged human brain samples.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 48,
      "key": "e31cf7a8bc78dd1434dc0ebf8c304924c5ff5d63206eeff20f02c302cbdfbbd9ee1377a0d484024248a12c1ba5de71359320dc00c9ee1d7f48ba6276a05c1b8e"
    },
    {
      "line": 398,
      "relation": "decreases",
      "evidence": " One study found that cytosolic Hsp90 was repressed in the superior frontal gyrus, while another demonstrated a similar repression in the prefrontal cortex of aged patients compared to controls (Berchtold et al., 2008; Loerch et al., 2008; Brehme et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "Anatomy": {
          "prefrontal cortex": true,
          "superior frontal gyrus": true
        }
      },
      "source": 30,
      "target": 48,
      "key": "bac622bce00ff1cbaac0a0db469fff5e6f096b4688120799417a210530757e0f16571ec9df4b1a2d3677ded6c5afdba758f258e65d2614ddc84d1e94e18eb426"
    },
    {
      "line": 405,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 57,
      "key": "532c23974fdddcaa13755f99a27ee2faedec8941907570be19515bfef35211ff685da103166a9dc311cdb9b686e0bf5f352797eeb1a0fa1f2749f568032ed12f"
    },
    {
      "line": 407,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 80,
      "key": "0f0ae02c8cb833df71248081cbf6926c8c97563044de00a5782907c25f44887b5c37be845605a8811b5ace3cbd11dab884c6280f9a52b2e22121a53d9523f5b4"
    },
    {
      "line": 408,
      "relation": "decreases",
      "evidence": " For instance, CyP40, FKBP52, PP5, Hop, p23, and Aha1 are all repressed in the aged brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 30,
      "target": 78,
      "key": "a2035d85442c931a254985f3463d2931e3598bed5dcc2a3b0fc4f3c4ba1d30ad81925d52fe0c835d2e28faa9ebc3c8b882aff8d77fcea7d512ed67b4b6f58726"
    },
    {
      "line": 463,
      "relation": "increases",
      "evidence": "These PTMs increase with aging and can alter the ability of Hsp90 to function properly as well as change the ability of diï¬erent co-chaperones to bind.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 51,
      "key": "df8bdf440f0b3676f1ef6ce7a4c0f848954bd0bbb44c59e6d31c64762bcc895c7c7aba7259591ed7f4776370c6a1665c05884ec73839c435c5281ef77617d36f"
    },
    {
      "line": 464,
      "relation": "increases",
      "evidence": "These PTMs increase with aging and can alter the ability of Hsp90 to function properly as well as change the ability of diï¬erent co-chaperones to bind.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 49,
      "key": "c0639eb3f44e909a242dace4332fe0d72636133f22002a7ac852a89b32a1dee1833895abfb1cabf58d6addccaf9b5bcf7fe89b6b7936636afdf6f04cb88cfee8"
    },
    {
      "line": 465,
      "relation": "increases",
      "evidence": "These PTMs increase with aging and can alter the ability of Hsp90 to function properly as well as change the ability of diï¬erent co-chaperones to bind.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 50,
      "key": "e09b27ba116d9c61cf06e26b7ee606b3755f0e91b09ea61d182a771c58a922ef94e1bbbc518ec1b75800063c898f8dc87cc481e2a0c3bcb0dd829ac422bd47ed"
    },
    {
      "line": 466,
      "relation": "increases",
      "evidence": "These PTMs increase with aging and can alter the ability of Hsp90 to function properly as well as change the ability of diï¬erent co-chaperones to bind.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 30,
      "target": 52,
      "key": "3bfc8da40394f121ab4962628293c8edc4a73f831614fc9c1cae89c2f20c59171e22af6ac2571f46332c29709b47bde11cd9ac09b347ea889843f080bab5a071"
    },
    {
      "line": 85,
      "relation": "association",
      "evidence": "Aging is the biggest risk factor for developing a neurodegenerative disease, but the speciï¬c factors which cause these predominantly sporadic diseases are still under investigation (Reeve et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 88,
      "target": 30,
      "key": "00d0331ef83d7e583421fa8924d9eddc1a32f79ec14ef738c0b72d2c43edb0de69ae3b3e2d140a8f3c371221fcecd0ff0ac96398ed05c2d82b524bbf2adc7446"
    },
    {
      "line": 108,
      "relation": "association",
      "evidence": "All of these chaperones assist in various ways to help fold, refold and degrade misfolded proteins.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 23,
      "target": 9,
      "key": "1ce519616cf87f46e38e04e7121dc73d276c1837dbf28ad50fa8cc907d14bc61228ca61f351316d154630c348164034c296fdffac97cc6052aa647de2af87792"
    },
    {
      "line": 109,
      "relation": "association",
      "evidence": "All of these chaperones assist in various ways to help fold, refold and degrade misfolded proteins.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 32,
      "target": 9,
      "key": "d6991120dde13752c032af528250ed3f19985979a25065e8986462393a26ff14349b26602372ca033f672ccc0ca3a5d641f828c69ffa882a371d08be191b83e7"
    },
    {
      "line": 438,
      "relation": "association",
      "evidence": "Hsp90 and Hop are both involved in the CMA system;",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 18,
      "target": 48,
      "key": "814e9f4656721a4793cd8e64ceb91c40a9db0e9704b77e7db0d4c88a8be45f67f5ad6b519334853589e0c1b155c5546be5e9575c5a90cd9a9a0d9f1ae0a01f77"
    },
    {
      "line": 439,
      "relation": "association",
      "evidence": "Hsp90 and Hop are both involved in the CMA system;",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 18,
      "target": 80,
      "key": "3d18b723dc60510fb3f5e83a85af6148e47d5bfa1dfaff9efb7819553c1932317ea07d87c62d8dbc78444fd05c769e1ee3a02d8ff416e82efd7e2aa7e3748c22"
    },
    {
      "line": 108,
      "relation": "association",
      "evidence": "All of these chaperones assist in various ways to help fold, refold and degrade misfolded proteins.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 9,
      "target": 23,
      "key": "b1ef696127e180bc9d66b50802b1ea725c2e233b1624fb9cb4ebc39827b60fba496420b4c1a18f1847949589033f6dfc10194f540869caa366092eb0822d0055"
    },
    {
      "line": 109,
      "relation": "association",
      "evidence": "All of these chaperones assist in various ways to help fold, refold and degrade misfolded proteins.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 9,
      "target": 32,
      "key": "fc7e350adbbd73c23af21fc30956ab0691c4b25a7aadb4d877275fad729e4b12a7a56e05747f26103f14b97ed2731a429a1006df7749d974dd609a9d29c1eba8"
    },
    {
      "line": 115,
      "relation": "increases",
      "evidence": "Hsp90 requires ATP to perform these functions including protein degradation, protein folding, prevention of protein aggregation, and protein modiï¬cation (EcheverrÃ­a et al., 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 14,
      "target": 48,
      "key": "490602b2b7707b7e7278ad8eac3b111fc2d722ebb76d1258ab814b9c1edbaa5fd1b91f786479e52fa05c5a7cda3845e57799cdb3cd4349ef44e7363adbe7e148"
    },
    {
      "line": 116,
      "relation": "increases",
      "evidence": "Hsp90 requires ATP to perform these functions including protein degradation, protein folding, prevention of protein aggregation, and protein modiï¬cation (EcheverrÃ­a et al., 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 48,
      "target": 32,
      "key": "4473378f0dd36f5e1199c85dc855421dc85285d2c35935473b20f5a7c852ea26c07c7adc7aa1e5fa96bd4dce4b008fd0364aa5d3446d14002450053199d1897c"
    },
    {
      "line": 117,
      "relation": "increases",
      "evidence": "Hsp90 requires ATP to perform these functions including protein degradation, protein folding, prevention of protein aggregation, and protein modiï¬cation (EcheverrÃ­a et al., 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 48,
      "target": 23,
      "key": "71836a417baabe08f6fe8a8fbe076f06bbdc8b014c23084b38a36c41b1eaf2889afdde17e932a5a698994a8704ac973861653c720e70ee9e9dd87745bcf2d1f5"
    },
    {
      "line": 118,
      "relation": "decreases",
      "evidence": "Hsp90 requires ATP to perform these functions including protein degradation, protein folding, prevention of protein aggregation, and protein modiï¬cation (EcheverrÃ­a et al., 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 48,
      "target": 91,
      "key": "51f702838e6060cbcaaeaece851c7de839b61c5b91650ea8f3d9af40923717a384299de1b6a370d8151324f2ad8eef0cb9b2d565de866f275c913e0dc736d2a4"
    },
    {
      "line": 137,
      "relation": "regulates",
      "evidence": " However, Hsp90 regulates tau and other aggregating proteins in coordination with a diverse group of co-chaperones (Schopf et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 91,
      "key": "083d488897274838cba655646f38fef44155117b8776ce66257d3d40ada431b6fe3fcdf398e35f2215d2d62e05828af962b980de626b1a9bb2d8ec085432d57e"
    },
    {
      "line": 119,
      "relation": "increases",
      "evidence": "Hsp90 requires ATP to perform these functions including protein degradation, protein folding, prevention of protein aggregation, and protein modiï¬cation (EcheverrÃ­a et al., 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 48,
      "target": 24,
      "key": "fd566a06888ce0524ec8e23198edcc6e60f2420929d4d1e941d944adbeecf7836f200c397cd8a92e033e657d660d134ac5af05166be172fdd1ad8733ab2ca537"
    },
    {
      "line": 136,
      "relation": "regulates",
      "evidence": " However, Hsp90 regulates tau and other aggregating proteins in coordination with a diverse group of co-chaperones (Schopf et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 5,
      "key": "4393f4e648ed6fb008ded48159206e85465f171d0be1cb9e6d31827f3db1d79bd3aa59925a20b9e9ac759dbbd6aeba76a29d01c612a63275d5541470e6e0ccff"
    },
    {
      "line": 142,
      "relation": "association",
      "evidence": "Hsp90 is critical to maintaining proteostasis (Brehme et al., 2014) and accounts for up to 6% of all protein within the cell during times of stress (Picard, 2002; Prodromou, 2016). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 29,
      "key": "973f86b95ed4e46a0293b815b3ddfe52399621da4e0c617b9b6b5e37a15f4c50dded376955994461f71fc3922e8b51c6df16e456ebcf7c4df534ec9d55f361ec"
    },
    {
      "line": 430,
      "relation": "increases",
      "evidence": " In addition to the problems faced with an overwhelmed chaperone network, the proteolytic activity of the proteasome also declines with aging, and in fact Hsp90 has been shown to protect the proteasome from age-related, oxidative-dependent decline (Conconi and Friguet, 1997). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 48,
      "target": 53,
      "key": "ef21faeb93ed69a7445bef2660cac1967a146dba3b69c006064e15bae4968b305bff9b4ba75bca6b299e90f54ff880e25a1b30243b08db12ceb211fc2ff90587"
    },
    {
      "line": 438,
      "relation": "association",
      "evidence": "Hsp90 and Hop are both involved in the CMA system;",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 18,
      "key": "9dc850e704e6ab887ce36383f5209f61adcb3684fc31d77156bd7bf233735284261e6d45adb1ae67c63d9fa1bca9577a9222fd41a0f717c429c782ccc03b36fb"
    },
    {
      "relation": "hasVariant",
      "source": 48,
      "target": 51,
      "key": "471a0658a9c0643caa9f40832a5730c759a26af52f4f29c57d8c69b072f22142f92725c0343b0a6cf4eb51a2d3b06d667a6d985ed96af61b1e794d700f4d7200"
    },
    {
      "relation": "hasVariant",
      "source": 48,
      "target": 49,
      "key": "a39436f6071a8f21672cd93795da3501b5270ee5c40f979b212866b9ab1a2536194fceaf17d2564fa0feca5ba20ab50fbf96b3ee29720108e79ca2ac3d56f703"
    },
    {
      "relation": "hasVariant",
      "source": 48,
      "target": 50,
      "key": "416ff13a2a89708c99db05b19f814803bb419680c0eb1f7ca198ce35905ddd7cb8e298a3f169d0563f6e74aa845babbb2626c758f2fafa00e728995a7c3486b0"
    },
    {
      "relation": "hasVariant",
      "source": 48,
      "target": 52,
      "key": "b21a9bfadc320fdf6b5642481298086b2e89633c006482d660eeeb3bbf56e88999c50a0f9673e9702f35b7f0ffe268d4ba68ab7eb255c7e103b523d9fff79055"
    },
    {
      "line": 471,
      "relation": "increases",
      "evidence": "Inhibition of the ATPase activity of Hsp90 has been shown to have positive outcomes in cell culture and animal models of tauopathy.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 48,
      "target": 94,
      "key": "9eddb48ffae4e0509a3dec5c90318d7925ec8284cb79faa42bdcf4bb0097a4737d36abde2097b49e7bd165c4cc54f6cfe063376fd68edac36eefbf4c1c9665eb"
    },
    {
      "line": 476,
      "relation": "increases",
      "evidence": "Previous studies have shown that Hsp90 inhibition decreased the levels of hyperphosphorylated and/or mutated tau species both in cells and mice.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 71,
      "key": "61cd26d337dd788961dc8199ddcecd39b21a7dfa69a9c12caffeb6161b6ac79bcc629150698e97fff49419e5a619fbca61865a671d7c2cf82e6f0962481524e4"
    },
    {
      "line": 477,
      "relation": "increases",
      "evidence": "Previous studies have shown that Hsp90 inhibition decreased the levels of hyperphosphorylated and/or mutated tau species both in cells and mice.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 48,
      "target": 74,
      "key": "1ab0bf979f4a10379d069b3486f0714fd1eec7999beaf0de734b6268ee8d686da0141649557d8350ed64feee7cf63684c03f81a52fc4a00eacb56c10b573e622"
    },
    {
      "line": 127,
      "relation": "increases",
      "evidence": " The pathological accumulation of tau is a hallmark in several neurodegenerative disorders collectively termed tauopathies (Kovacs, 2015); a series of diseases including Alzheimerâs disease (AD), progressive supranuclear palsy (PSP), Pickâs disease, and chronic traumatic encephalopathy (CTE; Guo et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 5,
      "target": 94,
      "key": "5ff5477afe15b89b013d04f64920416b97ba5b3c714f01a3a057280fd61bd36fe4ad35f9e10e61b202bc923ebdae7aeeb7d9266b3460d6963efd6b0e8dec8be0"
    },
    {
      "line": 237,
      "relation": "association",
      "evidence": "While a direct role of XAP2 in tau pathogenesis has not been described, studies have shown that XAP2 is activated by histone deacetylase (HDAC) 6, which has been linked to pathogenic tau (Kekatpure et al., 2009; Cook et al., 2012; Selenica et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 5,
      "target": 66,
      "key": "6c8d129a53a72103728c5c2e50139bd31347ec1d4406fe5c7c7797e12a05c5dba0c53fea82c001210335459430b34417faf38a4f24764fdad4c68d6d0d87edc9"
    },
    {
      "line": 244,
      "relation": "association",
      "evidence": " In addition, XAP2 coordinates with Hsp90 to regulate glucocorticoid receptor signaling (Laenger et al., 2009), which has also been implicated in the production of pathogenic tau (Pinheiro et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 5,
      "target": 21,
      "key": "7b8a6beb1cd56e5bcbfdb3ba4c70737a7724558771cc4d4cc339cfa08a7e714f00e91c023ad5a9ef2acb7d8fe5894fa57e9b87816f568fdd817d3f31bc163f73"
    },
    {
      "line": 128,
      "relation": "isA",
      "evidence": " The pathological accumulation of tau is a hallmark in several neurodegenerative disorders collectively termed tauopathies (Kovacs, 2015); a series of diseases including Alzheimerâs disease (AD), progressive supranuclear palsy (PSP), Pickâs disease, and chronic traumatic encephalopathy (CTE; Guo et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 83,
      "target": 94,
      "key": "b88d07e7796f52e8a2e9c8ca24b16210be8c5026ebdaaf13a72c2a4572b7db285abf58b9151845843f17c293139ef8218265ccbaa31065a2c3a6ced04a38e88a"
    },
    {
      "line": 191,
      "relation": "decreases",
      "evidence": "An interesting PPIase, CyP40, decreases in aging and is further repressed in AD (Table 1; Brehme et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 83,
      "target": 76,
      "key": "115a1c057d007b04fd19331ca5bfb23884682bac3f7678b375432186b987e1c3d74539a3990247697e56d28d10325a8a5c40fb4adc8d0fae8417c90640e60aab"
    },
    {
      "line": 217,
      "relation": "increases",
      "evidence": " However, throughout aging, FKBP51 levels progressively increase and are further increased in AD brain samples (Table 1; Blair et al., 2013; Sabbagh et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 83,
      "target": 58,
      "key": "37e6c7877ea7fedf486dcd2ce0d72110b91e7cbf9585099a434b4ff1d2f8fcf73b6dd5167318e3ce8af1ea8de100edf6a14bb2176a9028afbe723bdd543bc2ef"
    },
    {
      "line": 229,
      "relation": "decreases",
      "evidence": " However, it is interesting to note that FKBP52 levels are lower in the cortex of AD patientsâ brains (Table 1; Brehme et al., 2014; Meduri et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 83,
      "target": 57,
      "key": "e0d7f94e517fa3bf3f3f976bbc34bf921bcbac4323325331aeaf4d115811f39d78dd5b86ae7bab4a818825828fa8c89d967bfb924b2250a538ed88cb2fc71cda"
    },
    {
      "line": 252,
      "relation": "decreases",
      "evidence": " PP5 activity has been shown to be repressed in AD (Table 1; Liu et al., 2005). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 83,
      "target": 77,
      "key": "49f17ba95832cc25a1d675a7eb5b73b1997c268e47e38833983005f537ffd2e26383b2a1222387f7360d525bdb35daa2cdab973d04407aecac7dbe632d94d91e"
    },
    {
      "line": 258,
      "relation": "association",
      "evidence": "Studies have shown that PP5 is able to dephosphorylate tau at several phosphorylation sites connected to AD pathology (Gong et al., 2004). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 83,
      "target": 73,
      "key": "a9b06ee2c2bb4553e23572ab9178ed69c17dab0647605527c8bae27f150c54f78c16315fd70f929e3fd73a8bce83d81f52985a2c0b29b8d8c0fe8390fb807162"
    },
    {
      "line": 271,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 83,
      "target": 81,
      "key": "5c9c39ffee2e2ff436e5c6e015b81721e9ac5fc72ef3ce91d27c7b0948c0d74bf82e65e24577a88dd1ef2af2ceed80e317369752081815bc8c4914ad7018aaf6"
    },
    {
      "line": 309,
      "relation": "positiveCorrelation",
      "evidence": " Aha1 levels have been shown to increase with AD.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 83,
      "target": 54,
      "key": "fcd820439b6f1569e17e2f0f2301584c3a9693f78b40e3891c5f8bddaf7c8eda9c3f6b60a7547852d6beb5b144def924573b577a4706a3e35403179652558a29"
    },
    {
      "line": 129,
      "relation": "isA",
      "evidence": " The pathological accumulation of tau is a hallmark in several neurodegenerative disorders collectively termed tauopathies (Kovacs, 2015); a series of diseases including Alzheimerâs disease (AD), progressive supranuclear palsy (PSP), Pickâs disease, and chronic traumatic encephalopathy (CTE; Guo et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 92,
      "target": 94,
      "key": "7f721f5da9e41411bddda4cc7baf947eb350897b160886d015cc046467725f79204d140f39d41c7cb6deb53193c908ad491c3e7efcc1f9f7fef643c64b42c10b"
    },
    {
      "line": 130,
      "relation": "isA",
      "evidence": " The pathological accumulation of tau is a hallmark in several neurodegenerative disorders collectively termed tauopathies (Kovacs, 2015); a series of diseases including Alzheimerâs disease (AD), progressive supranuclear palsy (PSP), Pickâs disease, and chronic traumatic encephalopathy (CTE; Guo et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 90,
      "target": 94,
      "key": "0b5c7708cc4ce6383f0794a25dae880ea09b700b0d84391d43abd880e8cf43b293d9b2771c6eb1463448f25898fd7792b949feb49323d8519b00c2b0621b8806"
    },
    {
      "line": 131,
      "relation": "isA",
      "evidence": " The pathological accumulation of tau is a hallmark in several neurodegenerative disorders collectively termed tauopathies (Kovacs, 2015); a series of diseases including Alzheimerâs disease (AD), progressive supranuclear palsy (PSP), Pickâs disease, and chronic traumatic encephalopathy (CTE; Guo et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 84,
      "target": 94,
      "key": "2c595478c263f1ca3c37f6cfc2942ccdbb5c467964d3cae62c5b91056ae051e1d6fd8337de8702cd00123fd5d56e9623316a4e9830666f7c0bff208c0de1b81a"
    },
    {
      "line": 142,
      "relation": "association",
      "evidence": "Hsp90 is critical to maintaining proteostasis (Brehme et al., 2014) and accounts for up to 6% of all protein within the cell during times of stress (Picard, 2002; Prodromou, 2016). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 29,
      "target": 48,
      "key": "469579d2c6ee598f0dec235390692d6c4ed08adb85cbc1dca7ae94db08797e18b257341771cf938c85a1508e7a1e2cfc7d76194fee52df8e930f83b944305e39"
    },
    {
      "line": 151,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 67,
      "target": 27,
      "key": "824fb3ceefac081636eeb10019951f5833e9f8a3b459424d2a06ebc90302db314cf3fbba834ce7767002b312ca35b380d889116d7f9572fa8848bd62bbaac261"
    },
    {
      "line": 152,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 67,
      "target": 25,
      "key": "4ad20bc87cc4744c29469f7abb754c1606fbf95f872ad704c28e800d42758d004c38f6bafa80f6311fa2a93c9409e2899768edacaa7fbd91e982decd29e27224"
    },
    {
      "line": 153,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 67,
      "target": 31,
      "key": "fe5ae499c39b8a4051340a18dff1251e962f0a22f7694463999489d08cfa061199cffbe2284980e9b2cf319393f0e2e9941fbe2e31a445ef014b4655bf110001"
    },
    {
      "line": 154,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 67,
      "target": 87,
      "key": "5e833567da138c8729e21ae654d327dd8d4e6438c8e44178aabce8c2493202c695e51f3fb22c5bbdbf86b4000accbbb346c7077b4b113b9a7ba5e26aeb0fc370"
    },
    {
      "line": 151,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 27,
      "target": 67,
      "key": "e563ba5ae3c63d1fb204cc69a596a37f6d23c0b7d5324a6e9a6ea0494a5061a18dde35dbd44ecd2b18e17696434e5ffce8252545522500151efbb0815314d7b0"
    },
    {
      "line": 152,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 25,
      "target": 67,
      "key": "2ecf0b1c6871adb122d4db7025e03e68dd7a44d19670892d6dd851541731503d0989302b427b052d87b26ec2ec762198372e909b2b9b126bb17ead057071296e"
    },
    {
      "line": 153,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 31,
      "target": 67,
      "key": "907412261ef1db0319bdb1c5e11baaf9eac9236808aeab90846f1b2c84de6800676ddba4695571dbb4d362829a61ad2cc00f32188ece17e7cb874fbd7f1fd779"
    },
    {
      "line": 154,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 87,
      "target": 67,
      "key": "65b0a27bb394420f37fcd247ad0016a0dcdd809184c76f39c62482451c34d9f968bfc5494199ca9a411f0981b3c72bef2761522aab28c7b9275b753e2ac34434"
    },
    {
      "line": 155,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 68,
      "target": 20,
      "key": "faf537384e0d34dd15c2b5cce301c17d53e391cad1ba11e728b6619a037a91071e204e2c485a3c82fc1cfa561f4a22bcba649ada7567809fb3504b827fc1d19c"
    },
    {
      "line": 157,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Germ Cells": true
        }
      },
      "source": 68,
      "target": 17,
      "key": "e65254648cc2db52c74965ef5996f37fa9d9711654e9f10335be485871922902bd91bed5e5a0b5ac9f6f79b0cd07b3c77c2d10703c7305e81a54335d5f0e13d6"
    },
    {
      "line": 159,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 68,
      "target": 19,
      "key": "afd680540688a8e9a0f37500dfdd4f40929c3ed11943b8ec5a867992fe85212dd54d6db24ca2ce146ae2002cfc8045066c4f3ecfb249eef9e83b02da0a6e5ae6"
    },
    {
      "line": 160,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 68,
      "target": 26,
      "key": "a896e7a3c85d72dcb8a2dfbaa27ac6c379b24578df820740f0c317c20a1234f6393f5e4b91c4eb4d269ea6d8d6451ba74a367366371a3886a17b4d5d6ff47539"
    },
    {
      "line": 161,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 68,
      "target": 15,
      "key": "45f626641d8e8a231a960f8313f0e6473ad78e7765f62211a3feaf2c8b7cffaa149434184b6e0fef6b7a61caf2ffb8132dd9cd3ca020ee555b7e36c5375da779"
    },
    {
      "line": 155,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 20,
      "target": 68,
      "key": "81f1d6b248ad2604d350a9245428cd29e1533a008c8c1a34b516919888bdc69258f0d73dadc70f57e9418c6de17d04054fe045a31ca2e470fc73d2fc8b809087"
    },
    {
      "line": 157,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Germ Cells": true
        }
      },
      "source": 17,
      "target": 68,
      "key": "d84badfc3b0f2f328774128e1ed5d56ca4b34182a696219fdae3b146d0b2676263fdb22883ce0c3fb77faf4f0533312236573c8999f7a8c5a57e0a0aa9176548"
    },
    {
      "line": 159,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 19,
      "target": 68,
      "key": "32b0658de121a25b54133f336149e2a2e63435a04f82b1ca9bc9682eb0791a808253b5035053a12d049cc438ad1df7a80d6d9cba21212b32789ac8ce397e6908"
    },
    {
      "line": 160,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 26,
      "target": 68,
      "key": "4d0a044aafb864f3d47858404121c3633185e67b0dafc4c973612bb5e3ffbf2fbc14707d1ecddfd2aa408c31d406542462396f2cbc9b2758b5c064ab9a58fcfc"
    },
    {
      "line": 161,
      "relation": "association",
      "evidence": "Hsp90Î± is involved in growth promotion, cell cycle regulation, stress-induced cytoprotection, and cancer cell invasiveness; whereas Hsp90Î² is involved with early embryonic development, germ cell maturation, cytoskeletal stabilization, cellular transformation, signal transduction, and long-term cell adaptation (Eustace et al., 2004; Sreedhar et al., 2004).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 15,
      "target": 68,
      "key": "94dfdab29f0386c3fda6990f2b194088491d911467b0bb8eb57dc33caa5986798fff386ae83381f735005488e5847c36669be0d5e1896bc33d487a47e3494379"
    },
    {
      "line": 170,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 76,
      "target": 10,
      "key": "7568e45dcee534ddd86d61af2ed575ce21f3a59b18fcbbc66cb9d5c46f319ace81e46a7f039919569ce08b3736b5c2305fbbe3bed34504d2c748931f251c20c7"
    },
    {
      "line": 198,
      "relation": "decreases",
      "evidence": " CyP40 was recently shown to disaggregate tau ï¬brils in vitro and prevents toxic tau accumulation in vivo preserving memory, demonstrating a neuroprotective role for CyP40 in the brain (Baker et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 76,
      "target": 6,
      "key": "e5b7b7f0ac49862ced1f81e7e21ab9c878aea67a738066cceaac64604d95c3cb4b20546df39fed3d3ed7052b6bd849f82c4f6251ae0bb76557553e81aff5cdf0"
    },
    {
      "line": 199,
      "relation": "decreases",
      "evidence": " CyP40 was recently shown to disaggregate tau ï¬brils in vitro and prevents toxic tau accumulation in vivo preserving memory, demonstrating a neuroprotective role for CyP40 in the brain (Baker et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 76,
      "target": 5,
      "key": "7c9c849507e550dfac452d4e3cf380e69e3d253a9954fd56b45563d1f003551dcf91535c637777fc707b3364a5afdcd55ebf9ec4cf4514d91ed0ca997c543614"
    },
    {
      "line": 200,
      "relation": "increases",
      "evidence": " CyP40 was recently shown to disaggregate tau ï¬brils in vitro and prevents toxic tau accumulation in vivo preserving memory, demonstrating a neuroprotective role for CyP40 in the brain (Baker et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 76,
      "target": 28,
      "key": "353f53283117c398973ddab18bb17b177f29b5f422078254bce23bd9d89a0ff0f69dd14dfa8315af33d134e2d6e28daee0d0f16369ddfcba10fd7af8a687396c"
    },
    {
      "line": 202,
      "relation": "decreases",
      "evidence": " CyP40 was recently shown to disaggregate tau ï¬brils in vitro and prevents toxic tau accumulation in vivo preserving memory, demonstrating a neuroprotective role for CyP40 in the brain (Baker et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 76,
      "target": 22,
      "key": "77f880d84ca6e89fca41949ade168cc26004c581429472908e5e09f647a899c36024f6cb4a044e6a04942893d6262f598d8f5e8d154350b76d3d81c7264aca05"
    },
    {
      "line": 171,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 58,
      "target": 10,
      "key": "a34a1f32b500c192f46aafedaad18a6f05c8ccdd1bfaed1b77f5b8b1160d4899892b7669533c9ace2da532cb1b8dce8049bc1132e5d8a6dd2f364e2b573d1f5e"
    },
    {
      "line": 172,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 57,
      "target": 10,
      "key": "e443362ff98243f986a9294cfec8084ce3c56e1122e6b7cb7eedd3f5dbd2b32b8b3814c72400ab94558eca4fdc77076c5ef33b9cbea4fffa028d1a96d6053258"
    },
    {
      "line": 223,
      "relation": "increases",
      "evidence": "FKBP52 interacts both physically and functionally with tau and promotes tau aggregation in vitro (Giustiniani et al., 2015; Meduri et al., 2016). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 57,
      "target": 5,
      "key": "80f4db25899758303d6639a00b0e23fed3b33456ec796f9915763fd92c72f847b2457efa4e31846ade3d10206fd09121592be8c906c0fcd2e1d0ecb839fc8586"
    },
    {
      "line": 173,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 59,
      "target": 10,
      "key": "31bc0668705120cbcc05e51c5f9c7c8177f65ecdd59950a10da4bd13f4b52cdb87594194eecc8b324d3581e3c007593d650e9908b39ce1529e382ad438f61df2"
    },
    {
      "line": 174,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 60,
      "target": 10,
      "key": "eb1f591405bbf281015a8d273322c676b3c84a35f6a0c663c6651d36c91a5db7a47e4c029a1f0d1153e11946c51d611ab14919eed066dab8404bba386e672584"
    },
    {
      "line": 175,
      "relation": "isA",
      "evidence": "Hsp90 interacts with six immunophilins that display peptidyl- prolyl isomerase (PPIase) activity through TPR domains including cyclophilin 40 (CyP40) and ï¬ve FK506-binding proteins: FKBP51, FKBP52, FKBP36, FKBP38, FKBPL/WISp39 (Jascur et al., 2005; Jarczowski et al., 2009; Guy et al., 2015; Blundell et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 61,
      "target": 10,
      "key": "c0cadb5bd4fa5be26d604fb3f053d2ffbe90f501c8af3d67b6b7b04515d2c149366ea4fe8994059ccf137c49e9986856038b301486a90e01b6c90267ed120c52"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 48,
      "key": "7010bde8f7ffe3a6dc8e2d61a3975f8f044ca8ee574ed0d2d0539186398413cbfc83a66be1cfd4b83acfdc5eb752c9303d8921c458746b201dd021de4c979566"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 76,
      "key": "c2d102207df7dfc551d97dfe1d6c8f22bd9b5b9d28ede045efb93f718c5bec2c3ffadb70379e4ed9494d734fe2b8136472c132e76710af563cb25b6ce2e24181"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 48,
      "key": "b9d8e7ac539866fcd23aab6f53e4b3a1899c12c44c90f72ac52cf974840816dafc30de2705caad7b00a1e0029f01949b8bef371f434252e10a61406e405bf22f"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 58,
      "key": "997722743a6423408de2b721526a8e2db76b3af38d81af76abeabb6b2da093eb7d99d4721d95198e2b8d43504434be8aaefc7e554ee86fe588c051b90d9f0c43"
    },
    {
      "line": 210,
      "relation": "increases",
      "evidence": "Contrary to the neuroprotective eï¬ects of CyP40, two FK506- binding proteins (FKBPs) have been shown to stimulate toxic tau aggregation (Blair et al., 2013; Giustiniani et al., 2015; Kamah et al., 2016). One of these, FKBP51, coordinates with Hsp90 to preserve toxic tau oligomers in vivo (Blair et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 38,
      "target": 5,
      "key": "54fefceb1ddda4360606895bf9dc18d6d9e21639537f2fdc34ffc479dac3e0d691c670a302738b20fe64b6eab3476026b205e7950878b6b1cd2645d3e09b73e0"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 48,
      "key": "dfec6c0419125519896547258a950a545fd761955b4cfe157f01ce8f175b4045a5df7650f0dfe8daf34d076838415ad674391a008be3543d955c39eea1a8a941"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 57,
      "key": "9d62b40f6726f067d768ead64cb21038344ade7cf0bf056f112adf7760c48e197ec5de9270b791bfebc58639b5f04dc33ec33ff25872df55ce638e60f7d58cd5"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 48,
      "key": "41900f389531f61693f8a3b66d956ff3faaf57e6f9788942f72763246143b282be9a2a8912abd122786b81ae676a329cd3c732d5daadeeb5b409fa1dbae93b7e"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 59,
      "key": "a872e6861a16c2f9bbaad5863f1edf26b72c69a1ef5d1899d1b1e0e16f8a5a5eda24488a23cdde453b2550a82e8a802bb3bb10c5951375d1056c587f7a2a6d03"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 48,
      "key": "0c198788ead8b57a035d09e185ffb812aec4d0133cb6298f114d85f216c775a31e40ab40d466d4c210755332a88ec38aec77655e1b06964b2517a03c200a418b"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 60,
      "key": "de6df669b98d24ad5a880c6bc133a8b8782e644866d0ef109bbaaea55a3ed88f2e9327c1d5dae53c7280af4182a6a3efb8654b11148bc2d5cb2d923f973f5188"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 48,
      "key": "60b180e9403a6127801afb298244e4aeb763291079ba4aa93d52cde02b6ce0927fd27abd88fe393183db83a8c24ee6e85421f657a844bca1615c41fc94379245"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 61,
      "key": "8a1a15539c283447f5e2a5a873062fd963e70c36b984a6652b626518b217a1cdac321c3e5c0b1b774c63221514864e371aa00a4bca152f3e9a2778083c1e0903"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 48,
      "key": "f07c9c178829bbae4ac4cde457d6362eaa333596246af3744c5dd9bb5a0070a005342281629b6725b5c43bebe96ff6e7cff199f43f880ffe09d110a3c981c47a"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 77,
      "key": "b4510715177978f951d4a3304bab285bdeda4788e97900f1ecf7536b744977a78535e3d9a1b26099c683673d546ab059fcfdfb00e7c77db3b454884aa62e2e0d"
    },
    {
      "line": 257,
      "relation": "decreases",
      "evidence": "Studies have shown that PP5 is able to dephosphorylate tau at several phosphorylation sites connected to AD pathology (Gong et al., 2004). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 77,
      "target": 73,
      "key": "b468e52c6d32bde5015fed464a60d81c40f9597b6d32f2b4dffa0a5df184b5ffc65fda13d0f15b1b39a0bd2d35e0c69a805d45ac28cc25d0cf3a11ba9849f733"
    },
    {
      "relation": "hasComponent",
      "source": 34,
      "target": 48,
      "key": "69e9321af7d6242f6611162e531ce1b021bd6afa4a21714636e9a8dace9410cd3e2f2e3dc83099a6d5f2d04c217a36584eab44c56dbaa99545b560f7c6b9546c"
    },
    {
      "relation": "hasComponent",
      "source": 34,
      "target": 55,
      "key": "570cfb6c3172e244ae555dabaa73eb2c9f9acab054c3d3d65f2ea0f6f8a34699e89dd1962c8ed4d69250ada2b47a90d6fba21f5b4773c59c4fc2476218cd34af"
    },
    {
      "line": 243,
      "relation": "regulates",
      "evidence": " In addition, XAP2 coordinates with Hsp90 to regulate glucocorticoid receptor signaling (Laenger et al., 2009), which has also been implicated in the production of pathogenic tau (Pinheiro et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 34,
      "target": 21,
      "key": "5c2d98d8c7eaeaaf291920e59ef5456e784f29832f7a6fdc5fb512fabe296cdd8d602574b59b186d7f4b53222061ec03d2272896bef73f1cac7651bfc512d1fa"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 57,
      "key": "851eaa83d7210356f065dfaebabd21c3b0c077286a2d0716729eec8e1c05f32583ca5942c34c9437a200b1a132b77077829acd91f564100f111d8063b945bb5c"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 70,
      "key": "2268928c54a8dacf8dcdd4b8c114af6bae80eb98bd6c4f01668c202a8bf3664565351409d93d0c4373792bcf1dae0c4b58e2518ecb18378ca881c47d34ce40a4"
    },
    {
      "relation": "hasVariant",
      "source": 70,
      "target": 73,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "relation": "hasVariant",
      "source": 70,
      "target": 72,
      "key": "6a1d02ff262a505b4bd9395492c734f23e9b0b1431c0fa30a1eb886ecd32e77d6ca2271905db5f2e92bc53bd1e851ba4e6f903f9b26832caced4d5dc492ca7d3"
    },
    {
      "relation": "hasVariant",
      "source": 70,
      "target": 71,
      "key": "9fbd9218812f1cd82827e2d73f3b6af04acbe1f408aaedcdc53c6fc17a36272c67cdcc254874f5473ba4443fa19971fe4877420e735c04f4f7353480d8e1f8b2"
    },
    {
      "relation": "hasVariant",
      "source": 70,
      "target": 74,
      "key": "1f9bd7c2867036707fe963649511c37811b9c55d8f86d32aaf19a2b9ae43692126867debd9355b90aee88e793e854340f6276fe41c9492d1abb3c766f366e2e5"
    },
    {
      "relation": "hasVariant",
      "source": 70,
      "target": 75,
      "key": "22a66102eb7ed43a8161d57177ac2432b8efbfabab3d503feffcd533074b10723c8f4779d1742d699a20b9f2075e0382190e440d27216df7140376a51c33ac0c"
    },
    {
      "line": 236,
      "relation": "increases",
      "evidence": "While a direct role of XAP2 in tau pathogenesis has not been described, studies have shown that XAP2 is activated by histone deacetylase (HDAC) 6, which has been linked to pathogenic tau (Kekatpure et al., 2009; Cook et al., 2012; Selenica et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 66,
      "target": 55,
      "key": "ab7f970b007d46532600cdd2625de6695567f6b643bdaa7c0c62d9b397de55723fdfb516cddd487824e637fc3d6102eed11e49bcf4136e5bdefe117438698b9d"
    },
    {
      "line": 237,
      "relation": "association",
      "evidence": "While a direct role of XAP2 in tau pathogenesis has not been described, studies have shown that XAP2 is activated by histone deacetylase (HDAC) 6, which has been linked to pathogenic tau (Kekatpure et al., 2009; Cook et al., 2012; Selenica et al., 2014).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 66,
      "target": 5,
      "key": "00cb8fc677b7f7846f1e8c8c771b54954cc7d918f801e20ba6de8464004755b745fe3943b60dd3d6a6acef1bdc3118f6a647343239d62903171a946245140dcc"
    },
    {
      "line": 244,
      "relation": "association",
      "evidence": " In addition, XAP2 coordinates with Hsp90 to regulate glucocorticoid receptor signaling (Laenger et al., 2009), which has also been implicated in the production of pathogenic tau (Pinheiro et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 21,
      "target": 5,
      "key": "4e9acc8e1d11ba7e3f0fe61f896f83f66005fdeb47689b33a245ba2a248e85d4eb99d67932095d045df8d97af278e81b108aa75d098a60f81bca198ffa8ec527"
    },
    {
      "line": 258,
      "relation": "association",
      "evidence": "Studies have shown that PP5 is able to dephosphorylate tau at several phosphorylation sites connected to AD pathology (Gong et al., 2004). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 73,
      "target": 83,
      "key": "e59c1be3a8348806e16ba6a2993b649bec7ec23447a4ed29bead74c5bfa3a12c395c44cecabfe261cfb271597792054f7fda64e7e0d1049d47688c9f5b3b9150"
    },
    {
      "line": 263,
      "relation": "decreases",
      "evidence": "A previous study found that when Hop was depleted using siRNA, there was an accumulation of tau (Jinwal et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 80,
      "target": 70,
      "key": "e29ad08ac13c940ce476bdff915c8018af911c06735350a5510dd6f086efdedceac21afc5e2795d71bdcde65e654a56572081fb039de083901b8d0f10f429dc3"
    },
    {
      "line": 439,
      "relation": "association",
      "evidence": "Hsp90 and Hop are both involved in the CMA system;",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 80,
      "target": 18,
      "key": "6058d45ebe76d65b7845dc3b406f8df9d09325bd5f787e9475fb16e74633b01893235bf9ada3ceabe30a130692b2c31e5fc805af7e884f2d82072f2c3187bbd5"
    },
    {
      "line": 269,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 81,
      "target": 86,
      "key": "b362b6383d0569412572c8935cb0fbb05425d73563f85a54eeb66aaaba22ac12acc779f2e2ba1309dfef7a1760777b5c9318098de96a59d830426d5e87ffd0d7"
    },
    {
      "line": 270,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 81,
      "target": 89,
      "key": "9b72e332831d0d701d7c5242a1bd7b8fd4e0a4285dbd2d94554c45bc0d54cfacd12d7b64c56787604781b79e6669a6c92ca470d055b699de3ea002e4648222da"
    },
    {
      "line": 271,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 81,
      "target": 83,
      "key": "99c3a4dc286f924e8adcf46b4e33d7246bacf3e36626f99b8f2487c03ab268efe00d266987dced27999cc1990bc3abaa5d79417a5dfe621e1ee0c8d568c7b43d"
    },
    {
      "line": 272,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 81,
      "target": 85,
      "key": "78e0860f1e2a10b3fd341302a5f3ac3ba5cf01560b4909e0dc2cfc2e111fecfce724d83f6ea3c546a5bf05f9dafe37a1be160529364fc723d475c5f7c2287c32"
    },
    {
      "line": 273,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 81,
      "target": 93,
      "key": "951495ad08bb8d12773e01e492c5e78125ab8c9962e1df38d4e52a7461e25fe9d1aeae37c3e5391ba9b6932f2e11a873f100df5b1bb65a960438a86d74e08ae6"
    },
    {
      "line": 279,
      "relation": "increases",
      "evidence": " In tauopathic mice, CHIP regulates the removal of tau species that have undergone abnormal phosphorylation and folding (Dickey et al., 2007b).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 81,
      "target": 73,
      "key": "1adbae0d48ae6c7f13dfcade51d6fac48dc70b42afc6ddda495504a2f372e07ecc4f01e12c54188d3234c3ddbe303f687ced51f5bdc24f9cec4ce157255b7db2"
    },
    {
      "line": 280,
      "relation": "increases",
      "evidence": " In tauopathic mice, CHIP regulates the removal of tau species that have undergone abnormal phosphorylation and folding (Dickey et al., 2007b).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 81,
      "target": 72,
      "key": "4f0253fad8e234794774bf37d911b26f8f108d8f8886c55a416724734ceecaa505618355bc4ed9e7c5ac7a78d53c6ace5ffd3480acb27c5925400601e227c907"
    },
    {
      "line": 269,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 86,
      "target": 81,
      "key": "a7192aa930d414376794996c931b1e19ca6e4c2da39690665a6758b9dbe50e866fe67f510153890b11a47025661e6f3c0f00e8e368d019fff6f93c8e43dc62d1"
    },
    {
      "line": 270,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 89,
      "target": 81,
      "key": "26c92d8aeb86e812e25af88ee49391f41197391b9b920753bfcd4be14be65b7d407b0fa312bf5370bfde323b499ea5489a8fdefb82b8f2a1fc4339e52598a309"
    },
    {
      "line": 272,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 85,
      "target": 81,
      "key": "011df5fb16f092e1c83971d7b48b76b6a77cf721c02d07e8a133dd498e9810330140be82d99c915a40945c442168ced881bc4b4baec4e851409ef20aede2a10e"
    },
    {
      "line": 331,
      "relation": "association",
      "evidence": " Previous studies have also implicated Aha1 for a role in cystic ï¬brosis. ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 85,
      "target": 54,
      "key": "acf045988b3a632bec47e83f60c937dd7f4a6adfb40806e460d1d07b05b73995e342655c7b7776f0bd29ee40db73395860b2254f7eb1ee1f5981a877c34462ce"
    },
    {
      "line": 273,
      "relation": "association",
      "evidence": " CHIP has been linked to several neurodegenerative disorders including Huntingtonâs disease, Parkinsonâs disease and AD as well as other diseases such as cystic ï¬brosis and cancer (Dickey et al., 2007b; Edkins, 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 93,
      "target": 81,
      "key": "2956017ca6218f76a4339301ec4812d7e339d4627c7d4519f352173ec2fe404a595ba58a118991251ceb12a09c491c37bdd677a1db2bbdae5956fc66ccd71d85"
    },
    {
      "line": 355,
      "relation": "increases",
      "evidence": "p23 also plays an important role in preventing endoplasmic reticulum (ER) stress-induced cell death, which can be triggered by misfolded proteins, like tau (Rao et al., 2006; Abisambra et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 72,
      "target": 16,
      "key": "5a25af4500e158ce4dab065865ab7e90370f45942f566e07ec39775a9fad4ccf1b416235795ad0cfe9de4ed6576c477d41bf88fda699d00a9fc3bfed6b9f08fa"
    },
    {
      "line": 285,
      "relation": "decreases",
      "evidence": " One study found that in Drosophila, impaired Tom34 gene function led to enhanced tau pathology (Ambegaokar and Jackson, 2011). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 82,
      "target": 94,
      "key": "36073c3a4b2669e43ac89adc2ad2100ae236fa7cecf5a2174e7ea445725a29e5be7dd83f7e3e55fbb0dd5586c22f0b7572291d0bd14a9407cdeb3d82ed4a9dc1"
    },
    {
      "relation": "hasComponent",
      "source": 35,
      "target": 48,
      "key": "355ed552bb7c6dd1214f46eecc00b5f476b2f33823586a1a37600b1958e1a87798b7b46c7bc0eaab76dbdd47d442a09fb7be1b4e8be12037e39777fc04e0dffe"
    },
    {
      "relation": "hasComponent",
      "source": 35,
      "target": 56,
      "key": "8d0697a10dd446a46efabfaa752c068adbb2937c0dcac2e93e9e4c51d8987dcc0a30c5f35f9aa957fbfc1f2adab5fdd7723fa385b034a6fb8d958d3d3aadf2f8"
    },
    {
      "line": 292,
      "relation": "increases",
      "evidence": "Cdc37 is also required for the stable folding of protein kinases in coordination with Hsp90 (Calderwood, 2015). Many of these kinases are known to phosphorylate tau at sites associated with AD, such as GSK3Î² and MAPK13 (Taipale et al., 2012; Jin et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 35,
      "target": 65,
      "key": "f2dd89a88e23db9322caa7f6321251faad7fbe37516614ba3f210e411f2b4789ee5dc707f51e554490d23bf87072df5117d7899072ac434489ef47073839d8d1"
    },
    {
      "line": 293,
      "relation": "increases",
      "evidence": "Cdc37 is also required for the stable folding of protein kinases in coordination with Hsp90 (Calderwood, 2015). Many of these kinases are known to phosphorylate tau at sites associated with AD, such as GSK3Î² and MAPK13 (Taipale et al., 2012; Jin et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 35,
      "target": 69,
      "key": "8d75e463bbf9b2f612c55a155c368e9e3438c4ac3aeea9da4fa2e396d5d2395f112d52bca3485c4b7dfe5573541c4a96f2a8767b5936822e49e92cd46e188398"
    },
    {
      "line": 300,
      "relation": "increases",
      "evidence": " Interestingly, overexpression of Cdc37 preserves tau, and its suppression reduces tau (Jinwal et al., 2012).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 56,
      "target": 70,
      "key": "10546d8cf52d8564c9fc61e2a8fde4bbd54e8030c74138fdc265c6029202abe9312c65f6e70f6ef38d1fc581ec9f6caa330995a7f7f2962ea1834cc647012c13"
    },
    {
      "line": 294,
      "relation": "increases",
      "evidence": "Cdc37 is also required for the stable folding of protein kinases in coordination with Hsp90 (Calderwood, 2015). Many of these kinases are known to phosphorylate tau at sites associated with AD, such as GSK3Î² and MAPK13 (Taipale et al., 2012; Jin et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 65,
      "target": 73,
      "key": "c21aa9951195cecd6849998798453c241767ddf06cae4f81c38ab3f73d3a86c11130202eef7e0e8ab57b0556d5d89f4412597eaa2159bc42953c0a8ed48ff221"
    },
    {
      "line": 295,
      "relation": "increases",
      "evidence": "Cdc37 is also required for the stable folding of protein kinases in coordination with Hsp90 (Calderwood, 2015). Many of these kinases are known to phosphorylate tau at sites associated with AD, such as GSK3Î² and MAPK13 (Taipale et al., 2012; Jin et al., 2016).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 69,
      "target": 73,
      "key": "272711ec5f1a646f7b98ce48809a771644ca12c95efd7828c338bb80928599b77dfb03dd9a3353809ca00e05dca3dd950647e9ff5207ca634668d1e407ec0cea"
    },
    {
      "line": 305,
      "relation": "increases",
      "evidence": "The activator of Hsp90 ATPase homolog 1 (Aha1) works as a co- chaperone to stimulate the ATPase function of Hsp90 to regulate the folding and activation of client proteins.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 54,
      "target": 48,
      "key": "5531350c2b7ae5c22d1e12e6e77d8edeb48e1b922ec3e10275ef7f11255e584dc3f67fa6fa7b4dce7b25ab543e8527c45c92da5fe6e29f565645dc21dc5f6063"
    },
    {
      "line": 309,
      "relation": "positiveCorrelation",
      "evidence": " Aha1 levels have been shown to increase with AD.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 83,
      "key": "f58487eb131134d0d3318c5a9cc1df9ae7d2cff911eb16ee82c57e3ed5719971a9d0ad361add15301733ae908e1bbbe2a77ecb1972bb9eae39772439c16506ac"
    },
    {
      "line": 315,
      "relation": "increases",
      "evidence": " In the same study, we found that high levels of Aha1 in a tau transgenic mouse model increased tau oligomers as well as neuronal loss concomitant with cognitive deï¬cits (Shelton et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 7,
      "key": "f35392c5dbc36b9529ecf51a9c4e80ff626a58688d87ba4d53216ff52ba862ad10afbe335d5bb474ffa36286086eb885ec575dcad3de524f72ffa1cbbcaff8dc"
    },
    {
      "line": 316,
      "relation": "increases",
      "evidence": " In the same study, we found that high levels of Aha1 in a tau transgenic mouse model increased tau oligomers as well as neuronal loss concomitant with cognitive deï¬cits (Shelton et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 54,
      "target": 22,
      "key": "506940185b0cf35bc663f18a1657c1af4b00ba153c7372e722b6c14d406ee5d88305cb7fde30bd881c361630eb46235989d27f40139b2d90019861c9a1ff0ae7"
    },
    {
      "line": 325,
      "relation": "increases",
      "evidence": "Since Aha1 levels are repressed in aging, but are abnormally preserved in AD, tau aggregation could be accelerated in part by Aha1 in the AD brain.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 54,
      "target": 5,
      "key": "4b2a6275390262369d81b19b412e29c4685dd086d0580b7a4d20eba88a3ef04f8e9b0407cb8e005b83d4c9a58de3c03f7d427d9073e28668c150b3baf4bcb6fa"
    },
    {
      "line": 331,
      "relation": "association",
      "evidence": " Previous studies have also implicated Aha1 for a role in cystic ï¬brosis. ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 54,
      "target": 85,
      "key": "477582b93a53e8228b110654c61371127895593729c42cfd6e5e569ca09b6edcb7d7463f2b40143c46325662bf7fd3276ef79c54f81ae2e3000560fb78fa52ea"
    },
    {
      "line": 336,
      "relation": "decreases",
      "evidence": "p23 has an opposing eï¬ect on Hsp90 compared to Aha1. p23 works by inhibiting the ATPase activity of Hsp90.",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 78,
      "target": 48,
      "key": "6340c8a6ea43e75eae00cf9115346a12ef8f3992d37377f9663aa451990d65f3a5792bc21d584348542bc54c401e6355ca3afe5e127d1098bcdb68751829f178"
    },
    {
      "line": 342,
      "relation": "decreases",
      "evidence": " As a co-chaperone, p23 works to suppress protein aggregation and exhibits chaperoning activity, although p23 is not able to refold proteins on its own (Freeman et al., 1996).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 78,
      "target": 91,
      "key": "0c31fb64014e24817d392b46140119898a7fedc4b9847a70a5f6f2c918a2f1a8c9094d375c05765c2939522e6fff12d768fbcd1bcf0244fe8292198bd3c4da4d"
    },
    {
      "line": 347,
      "relation": "increases",
      "evidence": "Inhibition of p23 in an siRNA screen of Hsp90 co-chaperones showed that silencing p23 reduced both total and phospho-tau (Jinwal et al., 2012, 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 78,
      "target": 70,
      "key": "9a7c69405d678abde8d14c013ecc946ec898fd0192ab57a9e009d1c08bd50b432b4500237150213fa18f464014710dbe2ec3de2f109a05f04eaa304ece8d8010"
    },
    {
      "line": 348,
      "relation": "increases",
      "evidence": "Inhibition of p23 in an siRNA screen of Hsp90 co-chaperones showed that silencing p23 reduced both total and phospho-tau (Jinwal et al., 2012, 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 78,
      "target": 73,
      "key": "80a50e590cd709fb877153b11e5e0a5f7f958c9fffa2f11f24dabe0f7203beb20d2295243be791198bb411332d38942c3b06f5c74b3d7f9feba2f5905633dcf1"
    },
    {
      "line": 354,
      "relation": "decreases",
      "evidence": "p23 also plays an important role in preventing endoplasmic reticulum (ER) stress-induced cell death, which can be triggered by misfolded proteins, like tau (Rao et al., 2006; Abisambra et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 78,
      "target": 16,
      "key": "2b431253f2c3cfb298bfbba30b078adf9a3412b1c4cf9d884c0cf33781fbeeaff2c4fa562985aaa8ff072c4f4dc6baa5b7257d9cd7d00309901653c85b9f8384"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 48,
      "key": "0e62ddeb38eacb07514355be7fd1ec536ed8f70d10e1d4fd1aa1a0c13f76ddc255a994b03354b213d890007211559c1267d6e4b2aff6976b120168da248247fe"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 79,
      "key": "9a4de0dbdc6016312d8f62c712867d758b7bf6f023894e1f52cfc6c3d5e963111064ae3a8e6031ca2dac0f6c232f8c93ae4c4db78b553fe992f1fd8a30bd08ae"
    },
    {
      "line": 363,
      "relation": "increases",
      "evidence": "This study found that reductions in S100A1 also led to massive reductions in both phospho- and total tau levels in cells (Jinwal et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 79,
      "target": 70,
      "key": "98f9f42f4a02ba1691b5a646bae5ac582b06f9aac5e0a29e573491fca86e9585cfbe1e49280fa82848246e4e3dd877beee351c2a1c1866021fd5f1b42d4875a7"
    },
    {
      "line": 364,
      "relation": "increases",
      "evidence": "This study found that reductions in S100A1 also led to massive reductions in both phospho- and total tau levels in cells (Jinwal et al., 2013).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 79,
      "target": 73,
      "key": "8717b727c2093e57e0a32cef9c933fc7d2b13cffabeb2edf2b587143c0d3b2e1b86ea01a3f6cbc27c8a91cd6fd1d1b3565938becf1cd181e35b07b2e30ece9ed"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 48,
      "key": "6b63b3dbfe44ca11e6c6c31708f0906bc2bef56a28cd1b0f8c18f8aa659cca13d947658dc2c2b8b55d86ad3a599833d5537d1598332e973d8d52675d07926c31"
    },
    {
      "line": 369,
      "relation": "decreases",
      "evidence": "The folliculin-interacting protein 1 (FNIP1) is able to interact with Hsp90 as a co-chaperone in order to inhibit its ATPase activity. ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 42,
      "target": 48,
      "key": "27ec8f16dbc994bb5a7b3aa3bc828567655b5257098cefa46ea9f51bd7a98b7f85625b58424f142aaa2537c5451bf65504e5798f24236591132f0a77570fa13a"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 63,
      "key": "04851eaa376178c397f14b6ddc9b9f3f99f6acbb2b3da2e5f64f1162ece8870d8727e7cc2c935585a57a9f010a035b1d8747c87af02d05b91fa1d5fd110119fa"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 48,
      "key": "d18db27148748dd2eb8b9573c2246967e62ba4935c166168c9ab1c56058912000f04a91a64d54800c044bc47f77e08f6700201c8537272561359def906f6ff9a"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 63,
      "key": "d688f2b111543f4394bc704f98e5dde0938005415c4383b9cfc2945c2e69e738533bec3973660c3f8f8297c13cf8ecdb2c923a4e83ecb6375fbfb0fb6f78adbf"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 64,
      "key": "f37a82cb27d566b3d005f0e829b9f6f19695223b70a58788ca0c866180dab83c7f00bebcdd60be9fba3db2a4b61e5130064b8025dd616194e3481f5ed9c18b06"
    },
    {
      "line": 374,
      "relation": "increases",
      "evidence": "One study found that FNIP1, in complex with FNIP2 and Hsp90, was able to stabilize the tumor suppressor folliculin (FLCN; Woodford et al., 2016). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 43,
      "target": 62,
      "key": "90a378e168e185aa49538be1a1ca6053ae48fcd4ad4f5ce9d06ebdda712066d80d9dc04a6fb2a2abe1ead26e62e19994c2b7f59be84dc5cfcfed3654bf795fa2"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 48,
      "key": "48f0a9269c063aefd3037599dac228f6e847ad1e3b00742bd97174040553feeb409aacff8b0ba47cb04226f8a8bcfe46272ddf42e7bd080f7ac485980f9af6f2"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 57,
      "key": "1967e736842660a777f16e3a5505c1210603b879cde01a40338117025e53b6c47d25729b76a445a80e23bcde6529daba59ee607613bf539def235820b52621f0"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 78,
      "key": "f86e073c537d3fd126e9ef893c698972b69649850b3b4926ae6b9387d8ca96cfc597de72aa77e77c6415daff4542b5a925222761898dc06025feb0c3789e9720"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 80,
      "key": "728d5766863a76416f0b631a9d48eea55c4b3c221bbc8474b5f3f5d931f3c127d0da80c6d72e1ab60d29b929860e71ab945445ad09a5ad337ac8ecd949143d86"
    },
    {
      "line": 446,
      "relation": "decreases",
      "evidence": "Phosphorylation of Hsp90 leads to reduced chaperoning ability and phosphorylation of speciï¬c tyrosine residues can aï¬ect the ability of Hsp90 to interact with distinct client proteins (Zhao et al., 2001; Mollapour and Neckers, 2012).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 51,
      "target": 48,
      "key": "a8047096a99c8e6fd29bb250d717766e6955fa05613d178d17cc1aa123ecc2a887acd426cdfb3e48a334a79a1b4e29f6fdd8f5aeb5e6d775665c3e408a5bd34d"
    },
    {
      "line": 451,
      "relation": "decreases",
      "evidence": " Acetylation of Hsp90 aï¬ects client protein interaction and also decreases binding of Hsp90 to ATP (Yu et al., 2002; Mollapour and Neckers, 2012).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 49,
      "target": 33,
      "key": "15fd3ce3ea382ddeeccad65e7a5142cbb31aafcf3d9f850ef04eb166b6b14cd5024bfa888881f68609bb6553fbbd594d8f53286c7b56c25d1cd74c6440493e2e"
    },
    {
      "relation": "hasComponent",
      "source": 33,
      "target": 1,
      "key": "4748d3b3b6cf33d158d8878efd42cd8637151c2ae0652ae678fcc74e6c32b441fcb0afdb67197a7856ea5624578f0cb5975a73e2148082550d3c45045eb2a8f6"
    },
    {
      "relation": "hasComponent",
      "source": 33,
      "target": 48,
      "key": "ebc5e4e0a475bc8d00944201efeb1ac4b7866293052a188bd950b398516ded577aadeb4e3bf37c8f1ae1479706e6c2b6b9ed3fcbf0e04c991ef28652e7fe89bd"
    },
    {
      "line": 456,
      "relation": "decreases",
      "evidence": "S-nitrosylation, oxidation and ubiquitination also inhibit Hsp90 chaperone activity (Blank et al., 2003; MartÃ­nez-Ruiz et al., 2005; Chen et al., 2008).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 50,
      "target": 48,
      "key": "4cbb8b220c45c3d113f2b3481efa93b75525267ce8f4110b656a6401f1f38dc82d00db5da96097a730bca47fcc323e529a8b63cfbb50f60436a6a93f0d21573e"
    },
    {
      "line": 457,
      "relation": "decreases",
      "evidence": "S-nitrosylation, oxidation and ubiquitination also inhibit Hsp90 chaperone activity (Blank et al., 2003; MartÃ­nez-Ruiz et al., 2005; Chen et al., 2008).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 52,
      "target": 48,
      "key": "3b1967501280979d8eafd65f41a53164e3d951e574c36df33a93c470942a7608cb5095ecf22ddfcb7d15be6d2183e583e7a1ca075281818f0fea5517f74a951d"
    },
    {
      "line": 483,
      "relation": "increases",
      "evidence": "The Hsp90 N-terminal domain inhibitor, EC102, was used to demonstrate degradation of hyperphosphorylated pathologically relevant tau in cells (Dickey et al., 2007a).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 8,
      "target": 71,
      "key": "80d2d91624d051b191e2713e88ff12214b26cdff7b679c06533252cbbc401ef8bb47a68e58e57f2fd5e5b28e62b0d8b663b1c632222b15b5f6bcc3cc4627718c"
    },
    {
      "line": 491,
      "relation": "decreases",
      "evidence": " Another N-terminal Hsp90 ATPase inhibitor, 17- AAG, was shown to decrease levels of phosphorylated tau in cells, and a related N-terminal Hsp90 ATPase inhibitor, PU- DZ8, reduced soluble and insoluble tau in tauP301L mice (Luo et al., 2007).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 3,
      "target": 48,
      "key": "907597e58364b9f9781fbbdc56b29485f02564e5114c09d2a8b6fa61966163da47852fafbccaf2b14f40f131ead62bf13776678f0d98fcf4862e1a730683469e"
    },
    {
      "line": 492,
      "relation": "decreases",
      "evidence": " Another N-terminal Hsp90 ATPase inhibitor, 17- AAG, was shown to decrease levels of phosphorylated tau in cells, and a related N-terminal Hsp90 ATPase inhibitor, PU- DZ8, reduced soluble and insoluble tau in tauP301L mice (Luo et al., 2007).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 3,
      "target": 73,
      "key": "31e2ff96f2298cc08b903238e0ab1dab90192136e7bd0b415e540a0b7cb57b9db3ab84f259d062e3546e4d3fec8c57b7488f627aabfa286d735961cc17705980"
    },
    {
      "line": 493,
      "relation": "decreases",
      "evidence": " Another N-terminal Hsp90 ATPase inhibitor, 17- AAG, was shown to decrease levels of phosphorylated tau in cells, and a related N-terminal Hsp90 ATPase inhibitor, PU- DZ8, reduced soluble and insoluble tau in tauP301L mice (Luo et al., 2007).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ATPase activity"
        }
      },
      "source": 11,
      "target": 48,
      "key": "1852709d713f7a102051082ee2875927233e899fdfdd9d5092be9d488330793090e9150e416041015c7d037ea85d02e1e21927d17b1df431c417b1b0f120fe25"
    },
    {
      "line": 494,
      "relation": "decreases",
      "evidence": " Another N-terminal Hsp90 ATPase inhibitor, 17- AAG, was shown to decrease levels of phosphorylated tau in cells, and a related N-terminal Hsp90 ATPase inhibitor, PU- DZ8, reduced soluble and insoluble tau in tauP301L mice (Luo et al., 2007).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 11,
      "target": 70,
      "key": "89d03ec2f2f72ea1018e0cb1e2d28649a0c0e2170e75b4226a5125a4f9fcd61751f1c061213228b3b4cbe56d5fd644edc83d4f92b3392de03b8846d12690134f"
    },
    {
      "line": 503,
      "relation": "decreases",
      "evidence": "The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aï¬ect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 48,
      "key": "9b46276cb51b7c2087a9707bb799133d53babd22e919f9b7c6c137d8be6262e9628c63f742c1f48a3a7350ed7a4cf5368532103ded59ede46d7ec224dd6f3466"
    },
    {
      "line": 505,
      "relation": "decreases",
      "evidence": "The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aï¬ect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 2,
      "target": 70,
      "key": "300084c585919e344516fa8ab980522c0be04b3b72c51a9e8f0178fd61616cd5734b04569371e1afbb5223087a3a1b7ca9fe84a725f0d37c2cd98d363f11023b"
    },
    {
      "line": 504,
      "relation": "decreases",
      "evidence": "The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aï¬ect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 0,
      "target": 48,
      "key": "429d121dfbfdf939304d786e50cc523040a54dd05280fed0dc2106199c33d754d1a5fbb3255fb3fa1f6b231fd176c636af4bc02a5e2fcd6f746a8c870ca14215"
    },
    {
      "line": 506,
      "relation": "decreases",
      "evidence": "The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aï¬ect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 0,
      "target": 70,
      "key": "d4c1ea7629e162180af71e23d57f4f96809553628ad6f7ddf38171ef6df3d473fc247fd211fee232769b5b2d185028ad3762245bcdf307e352871ba20ca8de80"
    },
    {
      "line": 507,
      "relation": "decreases",
      "evidence": "The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aï¬ect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 12,
      "target": 35,
      "key": "22538a3567c5a564fa6ddb85b211b53f580ced8c60b9621a5583a223d1631e5685129c9fdebca064936b09cc7088b222e75ed47c425d558470399602fb54c0ca"
    },
    {
      "line": 513,
      "relation": "decreases",
      "evidence": "Interestingly, one study demonstrated that patients chronically treated with FK506, which inhibits the PPIase domain of many of the FKBPs, signiï¬cantly reduced the incidence of AD (Taglialatela et al., 2015).",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 13,
      "target": 83,
      "key": "0d16e45fc0c1a0235ac4db592d8d25fcea2e69e868f270e89089410b5dab576c2ec03d669745343fa64b3dfeb1786c375a0ab49126858b0b416fb84e88825eba"
    },
    {
      "line": 519,
      "relation": "decreases",
      "evidence": "Additionally, Aha1-speciï¬c inhibitors have been recently developed (Hall et al., 2014). One of these inhibitors, KU-177, reduced insoluble tauP301L levels in cells (Shelton et al., 2017). ",
      "citation": {
        "type": "PubMed",
        "name": "Frontiers in neuroscience",
        "reference": "29311797",
        "title": "Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.",
        "volume": "11",
        "pages": "724",
        "date": "2017-01-01",
        "first": "Shelton LB",
        "last": "Blair LJ",
        "authors": [
          "Blair LJ",
          "Koren J 3rd",
          "Shelton LB"
        ]
      },
      "source": 4,
      "target": 75,
      "key": "5798cd1a6290e34f50636065ef7784a9a9c6e4dcc11146b9eb5611d38a96ccccf4086dc4d79c1d965a80b298d080e9992d681fcf10e090b091177b4e2f2a797b"
    }
  ]
}